The impact of endocrine disruptors on female pubertal timing by Bourguignon, Jean-Pierre & Parent, Anne-Simone
325E. Diamanti-Kandarakis and A.C. Gore (eds.), Endocrine Disruptors and Puberty, 
Contemporary Endocrinology, DOI 10.1007/978-1-60761-561-3_13, 
© Springer Science+Business Media, LLC 2012
 Abstract  Secular changes in pubertal timing and particular forms of sexual precoc-
ity after migration to new geographical areas whose levels of environment differ 
from those in the natal country suggest that endocrine-disrupting compounds 
(EDCs) may be involved. Studies in humans based on measurement of some EDC 
in relation to pubertal timing are inconclusive for several possible reasons including 
predominant genetic determinism and effects of complex EDC mixtures. Based on 
animal models, some possible neuroendocrine mechanisms are discussed as well as 
the interrelation between the homeostasis of reproduction and energy balance. 
 Keywords  Adiponectin •  DDE •  Development •  DDT •  Energy balance •  GnRH 
•  Homeostasis •  Intrauterine growth retardation •  Leptin •  Menarche •  Nutrition 
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 Pubertal Timing as an Endpoint for Endocrine Disruption 
 Female puberty is the life period when pituitary–ovarian maturation leads to a series 
of physical changes: initially, onset of breast development and increased height and 
weight gain; ultimately, fi rst menses (menarche) followed, after months or years, by 
regular (ovulatory) cycling. A central event in the onset of puberty is an increase in 
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frequency and amplitude of gonadotropin-releasing hormone (GnRH) secretion in 
the hypothalamus. This event is controlled by redundant inhibitory and excitatory 
mechanisms that are respectively inactivated and activated at the onset of puberty 
 [ 1 ] . For initial pubertal signs (breast development) or subsequent events (menar-
che), it is generally agreed that timing can vary physiologically within a 5-year 
period. These variations are predominantly determined by genetic factors, while 
environmental factors play a comparatively minor role  [ 2 ] . A striking refl ection of 
environmental effects on pubertal timing arose through the secular advance in 
menarcheal age. Since this was observed between the mid-nineteenth and the mid-
twentieth centuries both in USA and Western Europe and more recently in develop-
ing countries  [ 2 ] , improvements in health and nutritional status with industrialization 
were thought to be an explanation. The end or slowdown of this process between 
1960 and 2000  [ 2 ] was consistent with that explanation. Two large American stud-
ies published around the year 2000  [ 3,  4 ] and, very recently, fi ndings obtained in 
Denmark and Belgium  [ 5,  6 ] provided evidence of earlier onset of puberty. However, 
onset of breast development, an initial sign, was more affected than age at menar-
che, a relatively fi nal pubertal sign  [ 3– 6 ] . Moreover, the age distribution of pubertal 
signs showed recently skewing toward earlier ages for initial signs  [ 6,  7 ] and toward 
later ages for fi nal signs  [ 6 ] . The latter fi nding is consistent with a French study 
showing that the secular trend toward earlier menarcheal age was associated with a 
trend toward later occurrence of regular (ovulatory) cycling  [ 8 ] . Because those 
changes in pubertal timing were concomitant with the epidemic of obesity in USA, 
the pathophysiological involvement of fat mass, possibly through leptin  [ 3,  4,  9 ] , 
was hypothesized in that country. However, the early breast development reported 
recently in Denmark was not signifi cantly associated with changes in adiposity  [ 5 ] . 
Thus, the possible involvement of other factors such as endocrine-disrupting chemi-
cals (EDCs) was postulated to account for the current secular changes in pubertal 
timing  [ 10 ] , though no direct evidence substantiates that hypothesis so far. 
 Suggestive evidence of environmental effects on female pubertal timing also 
came from studies in children migrating for international adoption. As cohorts, they 
appeared to mature earlier than children in the foster countries and in the countries 
of origin  [ 2,  11 ] . Also, sexual precocity requiring treatment was seen in those 
migrating children much more frequently than in others  [ 12,  13 ] . Increased serum 
levels of DDE, a persisting derivative of the estrogenic insecticide DDT, were found 
among migrating children. We therefore hypothesized that early exposure to this 
EDC and subsequent withdrawal due to migration could account for a neuroendo-
crine mechanism of secondary central precocious puberty in those girls  [ 2,  12 ] . 
Using an immature female rat model exposed during early postnatal life to DDT for 
5 days, we have been able to induce sexual precocity with involvement of hypotha-
lamic mechanisms  [ 14,  15 ] . The involvement of DDT in the pathogenesis of sexual 
precocity in migrating girls could be further substantiated by the observation of 
lower serum DDE or DDT levels in the girls with normal or late pubertal timing 
than in precocious girls. Direct evidence, however, is lacking and diffi cult to obtain 
since those girls have no reason to attend the clinic and have a blood sample drawn. 
Moreover, many other EDCs could have affected the migrating children in early 
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life, whereas they cannot be identifi ed several years later. Other factors including 
recovery from earlier nutritional as well as psychosocial deprivation could play 
some role as well  [ 16 ] . One further example suggesting EDC-related development 
of sexual precocity inferred from geographical clusters of children has been reported 
in Italy, where the mycotoxin zearalenone has been incriminated in increased fre-
quency of sexual precocity  [ 17 ] . 
 Association Between Exposure to Endocrine Disruptors 
and Variations in Human Female Pubertal Timing 
 Linking exposure to particular EDCs and physiological or abnormal variations in 
pubertal timing is a challenge for several reasons  [ 18,  19 ] . Humans as well as ani-
mals are likely exposed simultaneously to a variety of EDCs acting as mixtures that 
change in composition and dose with time. Since compounds mixed at concentra-
tions that are inactive when used as single EDCs have been shown to become active 
when used as mixtures  [ 20 ] , the signifi cance of studies on single-EDC effects is 
limited, and addition of the effects of several individual EDCs cannot predict the 
effect of mixtures. The study of mixtures, however, is complex and laborious. So 
far, studies on EDC effects on pubertal timing have been performed with single 
classes of EDCs only. When exposure is assessed at the time of pubertal develop-
ment or disorders, the identifi ed EDCs could be different from those which were 
acting during fetal/perinatal life, a most critical time for EDC effects on pubertal 
timing  [ 20,  21 ] . Keeping in mind that the relevance of the studied relationship 
between EDCs and pubertal disorders is limited due to the above reasons; the avail-
able information mainly based on the study of single EDCs is summarized in 
Tables  13.1 (breast development) and  13.2 (menarche). Prenatal and postnatal expo-
sures are separated whenever possible. 
 Links between EDCs and puberty have been evaluated in some experimental 
studies. After exposure to the insecticide DDT or its derivative DDE, discrepant 
data were obtained since early onset of breast development  [ 12 ] and early menarche 
 [ 22,  23 ] were observed in some studies, whereas others found female pubertal tim-
ing to be within normal age limits  [ 24– 26 ] . In the female monkey, delayed nipple 
growth and short follicular phase were seen after exposure to the pesticide methoxy-
chlor  [ 27 ] . The timing of breast development was not affected after exposure to 
polybrominated biphenyls (PBBs) or polychlorinated biphenyls (PCBs)  [ 24,  26,  28, 
 29 ] . Early menarche, however, was reported after exposure to PBBs  [ 28 ] or PCBs 
 [ 25 ] , though several studies found no alteration of menarcheal age in association 
with PCBs  [ 22,  24,  29,  30 ] . Dioxins differentially affected timing of breast develop-
ment that was delayed  [ 29,  31 ] and timing of menarche that was normal  [ 29,  31,  32 ] . 
Early breast development was reported in association with postnatal exposure 
to phthalates  [ 33,  34 ] . Phytoestrogens were associated with delayed timing of breast 
development  [ 26,  34 ] but no effects on menarcheal age  [ 35 ] . The discrepant fi ndings 
for breast development and menarche emphasize the importance of studying 
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 different pubertal signs, possibly involving different mechanisms at several times 
throughout the pubertal process. Overall, those studies did not enable a differentia-
tion of effects depending on prenatal or postnatal period of exposure to the EDCs. 
 Possible Mechanisms of EDC Effects on Female Sexual 
Maturation 
 Overall, most EDC interactions with sex steroid effects are translated into either estro-
gen agonist action or androgen antagonism with the ratio of estrogen/androgen actions 
as an ultimate determinant  [ 36 ] . In concordance with this concept, premature breast 
development can occur after exposure to phthalates that are considered to act primar-
ily as androgen antagonists  [ 33 ] . Because sex steroids can act at the different levels of 
the hypothalamic–pituitary–gonadal system (Table  13.3 ), the imbalance between 
estrogen and androgen effects caused by EDCs potentially affects all those levels. 
Direct disruption of the peripheral female reproductive system involves predomi-
nantly effects mimicking estrogens  [ 19 ] . Such direct peripheral effects of EDCs could 
infl uence the circulating levels of endogenous peripheral hormones. Then, changes in 
neuroendocrine and pituitary function could result indirectly from altered peripheral 
feedback. Alternatively or additionally, changes in hypothalamic and pituitary func-
tion could result directly from EDC neuroendocrine effects as illustrated by alteration 
of the preovulatory gonadotropin surge following exposure to sex steroids during fetal 
or perinatal life  [ 37 ] . Female pubertal development can involve either hypothalamic–
 Table 13.3  Some possible mechanisms of EDC maturational effects on the hypothalamic– 
pituitary–gonadal system in female individuals 
 Level possibly targeted by EDCs 
 Developmental effects
 of increased estrogen/androgen 
balance  Mechanisms 
 Central nervous system: 
suprahypothalamic afferents 
 Structural changes?  Primary central/
neuroendocrine 
or secondary 
to altered feedback 
effects of gonadal 
hormones 
 Hypothalamus: GnRH neurons 
and surrounding neuronal–
glial system 
 Facilitation (or inhibition) 
of pulsatile GnRH secretion 
 Female more sensitive than the 
male? 
 Alteration of sexually dimorphic 
control of ovulation 
 Pituitary gland: gonadotrophic 
cells 
 Early pubertal stimulation or 
increased prepubertal 
inhibition (negative feedback) 
 Response to neuroen-
docrine effects or 
peripheral feedback 
 Gonads: sex steroid production/
effects and gametogenesis 
 Alteration of folliculogenesis  Primary peripheral or 
secondary to altered 
neuroendocrine 
control 
 Peripheral tissues: Sex steroid 
effects 
 Early/increased stimulation 
of estrogen-sensitive tissues 
(breast, uterus) 
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pituitary maturation that will  secondarily increase sex steroid  secretion or direct 
peripheral interaction in the tissues targeted by sex steroids or both mechanisms. 
 Due to obvious limits in assessment of neuroendocrine function in the clinical 
setting, the use of experimental models is required to tackle neuroendocrine effects 
of EDCs. We exposed female rats early and transiently to DDT in order to mimic the 
conditions thought to account for sexual precocity in girls migrating for interna-
tional adoption  [ 2,  12 ] . Because fetal or early postnatal exposure to testosterone or 
estradiol would masculinize the CNS and alter the neuroendocrine mechanism of 
estradiol stimulation of GnRH secretion  [ 38 ] , the animals were exposed to DDT 
starting postnatal day 6 until day 10. Ex vivo study of GnRH release from hypotha-
lamic explants showed premature acceleration of pulsatile GnRH secretion, early 
vaginal opening, and early fi rst estrus  [ 14 ] . Further evidence of possible hypotha-
lamic–pituitary effects of DDT in vivo was obtained through a premature develop-
mental reduction in LH response  [ 14 ] . Our interpretation of sexual precocity after 
migration  [ 2,  14 ] is that during exposure to DDT, estrogenic effects can account for 
both peripheral and central (neuroendocrine) stimulation. However, due to concom-
itant negative feedback inhibition at the pituitary level, the central effects are not 
translated into gonadotropin stimulation of the ovaries until the pituitary inhibition 
disappears following migration in a DDT-free environment. In a study of interna-
tionally adopted girls aged 5–8 years, Teilmann and coworkers  [ 39 ] reported that 
serum FSH and estradiol levels were already elevated in several girls before they 
eventually showed clinical evidence of sexual precocity, confi rming early pituitary–
ovarian activity after migration. The above mechanism is comparable to that operat-
ing in other conditions with peripheral precocious puberty (e.g., congenital adrenal 
hyperplasia, adrenal or gonadal tumors) followed by secondary central precocious 
puberty after the peripheral disorder is cured by medical or surgical treatment  [ 2 ] . 
Consistent with this concept, central precocity should not be manifested in condi-
tions of persisting exposure to DDT. We attempted to demonstrate that continued 
administration of DDT to the female rats was not associated with evidence of preco-
cious central maturation, but we failed due to toxic effects including malnourish-
ment and growth failure  [ 14 ] . 
 The effects of EDCs on sexual maturation in laboratory rodents were reviewed 
previously  [ 40 ] . Using triphenyltin in the female rat  [ 41 ] and phthalates in the male 
 [ 42 ] , peripheral effects can be biphasic, low or high doses causing early or delayed 
puberty, respectively. In the few studies where hypothalamic–pituitary function was 
assessed, LH secretion was reduced together with early vaginal opening after DES 
 [ 43 ] or irregular cycling after BPA  [ 44 ] . Still, the possibly coexisting central and 
peripheral effects remain a matter of confusion, and the early developmental reduc-
tion in LH secretory response to GnRH in the rat  [ 14 ] is diffi cult to separate from 
negative feedback inhibition. As another example, BPA administration to neonatal 
female rats for 4 days resulted in early vaginal opening and acyclicity but no change 
in sexual receptivity and FOS induction in GnRH neurons after steroid priming 
 [ 45 ] . This suggests predominant peripheral effects in those conditions and high-
lights the importance of simultaneous study of central and peripheral effects. 
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 Further elucidation of EDC involvement in the neuroendocrine mechanism of 
female sexual precocity may come from recent progress in identifi cation of estro-
gen-responsive cells – neurons and/or glial cells through expression of ER alpha 
and/or ER beta and nongenomic effects and estrogen-responsive genes. Based on 
murine and ovine animal studies on the sex steroid feedback control of the ovulatory 
cycle, it appears that GnRH neurons are unlikely to respond directly to stimulatory 
effects of estrogens that are mediated through afferent neurons  [ 46– 48 ] . Among 
them, the kisspeptin neurons appear to play an important role as estrogen-sensitive 
fi nal gate to the GnRH neurons  [ 48,  49 ] with a gender dimorphism that could 
account for the female predominance of sexual precocity. This mechanistic hypoth-
esis is consistent with preliminary data showing higher peripheral kisspeptin levels 
in patients with precocious puberty than in controls  [ 50 ] . Not only estrogens or 
estrogenic compounds of peripheral or environmental origin could infl uence that 
system but also locally originating estrogens through brain aromatase  [ 51 ] . 
Nongenomic interactions of estrogens with the GnRH neurons were reported besides 
the effects mediated through kisspeptin neurons in the monkey  [ 52 ] . Recent studies 
indicate that kisspeptin expression or kisspeptin fi ber density in the rodent hypo-
thalamus is reduced after neonatal exposure to BPA  [ 53 ] or genistein  [ 54 ] , respec-
tively. Though these data suggest negative feedback effects of those EDCs, further 
studies with emphasis on developmental changes are needed to substantiate or 
invalidate the involvement of kisspeptin in possible stimulatory effects of EDCs on 
pubertal timing. 
 Female Sexual Precocity: An Early Homeostatic Disturbance 
Involving the Control of Reproduction and Energy Balance? 
 The hypothalamic–neuroendocrine system is a common integrative site for regula-
tion of homeostasis including reproduction and energy balance. That regulation 
likely involves, during fetal and neonatal life, programming mechanisms that account 
for the “developmental origin of health and diseases”  [ 55 ] . Peripheral messengers 
from the gonads (e.g., sex steroids) and from adipose tissue (e.g., leptin, adiponec-
tin) can also play important regulatory roles in linking energy balance and reproduc-
tion throughout life. In Table  13.4 are proposed some of the connections between 
homeostasis of reproduction and homeostasis of energy balance, throughout life, as 
discussed in two recent reviews  [ 20,  21 ] . Feto-maternal malnourishment or over-
feeding with fat as well as fetal exposure to sex steroids or EDCs such as DES and 
BPA were shown to possibly result in low birth weight, early puberty, ovulatory 
disorders, obesity in adulthood, and metabolic syndrome  [ 55– 58 ] . Some of those 
effects are sexually dimorphic since DES causes a metabolic syndrome in female but 
not in male mice  [ 56 ] . Both sex steroids and leptin are involved in early organiza-
tional effects in the hypothalamus that could affect, respectively, the central control 
of reproduction  [ 59 ] and energy balance  [ 60 ] . There are several lines of experimental 
and clinical evidence of cross talk between the systems controlling reproduction and 
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 Table 13.4  Some characteristics shared in disorders of homeostasis of reproduction and energy 
balance 
 Environmental 
stressors in fetal life 
 Endocrine-disrupting 
chemicals (EDCs)  Under- / Over-feeding 





















 Disorders of sex 
differentiation 
 Low birth weight  Combined anomalies 
 Late manifestations  Disorders of puberty 
and reproduction 
 Obesity and 
metabolic 
syndrome 
 Combined anomalies 
energy balance. During postnatal life, leptin is an important link between energy 
balance and reproduction through facilitatory effects on GnRH secretion  [ 2,  61 ] . 
Clinically, cross talk is supported by the recent fi nding that rapid weight gain in 
infancy between birth and 9 months predicts increased adiposity at 10 years and 
early menarcheal age  [ 62 ] . Ibanez et al.  [ 63 ] reported that intrauterine growth retar-
dation (IUGR) was associated with increased risk of premature pubarche, hyperin-
sulinism, ovarian hyperandrogenism, and polycystic ovary syndrome (PCOS). Of 
particular interest is the observation that IUGR is associated with increased visceral 
adiposity and reduced serum levels of adiponectin in childhood  [ 64 ] . The latter effect 
parallels BPA-induced reduction of adiponectin production by adipocytes  [ 65,  66 ] . 
All together, those fi ndings suggest that both the reproductive and energy balance 
systems share a possible fetal/early postnatal determinism of disorders such as sex-
ual precocity under the infl uence of early nutritional conditions and/or early expo-
sure to EDCs, with mechanistic cross talk between the two systems. 
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